Sleep Number (SNBR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Executive summary
Leadership transition in April 2025 focused on operational streamlining, cost reduction of $136 million compared to 2024, and extension of bank agreement through 2027.
Launched "Sleep Number Shifts" strategy to reposition the brand, simplify product offerings, reshape marketing, and expand distribution channels.
Board and management are committed to enhancing governance, with several proposals requiring two-thirds shareholder approval.
Annual Meeting scheduled for May 21, 2026, to be held virtually.
Voting matters and shareholder proposals
Election of three directors for three-year terms.
Proposals to declassify the Board, eliminate supermajority voting requirements for directors and certain transactions, ratify Deloitte & Touche LLP as independent auditors, approve executive compensation (Say on Pay), and amend the 2020 Equity Incentive Plan to add 750,000 shares.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Board reduced from 12 to 7 members since 2025, with ongoing refreshment and diversity in skills, gender, and experience.
Board structure changes proposed: declassification and annual elections starting 2027, subject to shareholder approval.
Majority of directors are independent; separation of Chair and CEO roles maintained.
Three standing committees: Audit, Compensation, and Corporate Governance & Nominating.
Regular board and committee evaluations, with independent third-party facilitation as needed.
Latest events from Sleep Number
- Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025 - Q1 2025 sales dropped 16% with a $8.6–$9M net loss, but gross margin rose to 61.2%.SNBR
Q1 202523 Dec 2025